Navigation Links
EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate

LEXINGTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) announced today positive cognitive function results from its Phase 1b multiple ascending dose clinical trial of PRX-07034, the company's internally-discovered, novel 5-HT6 antagonist being developed for obesity, Alzheimer's disease and cognitive impairment associated with schizophrenia.

The randomized, double-blind, placebo-controlled Phase 1b, multiple ascending dose clinical trial was designed to study the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRX-07034 administered orally once-daily for 28 days in a population of obese, but otherwise healthy, adults (average weight 100kg or 220 pounds). The 33-person trial, which was conducted in an in-patient setting, included measures to assess potential effects on cognitive function and obesity. Highlights from the study include: -0-

-- Primary endpoint: safety and tolerability.


    -- PRX-07034 was well tolerated up to 600 mg once per day. No dose

       limiting toxicity was identified, and no serious adverse events

       were reported. There were no withdrawals due to adverse events.


    -- PRX-07034 demonstrated predictable pharmacokinetics with dose

       proportional increases in exposures, and a half-life supporting

       once-daily administration.


-- Secondary endpoint: cognitive function (CogScreen(TM) test

   battery).


    -- Overall results on cognitive function showed a dose-dependent

       trend for improvement associated with PRX-07034.


    -- For the predetermined endpoint that combines speed and

       accuracy, there was a dose-dependent effect which was

       statistically significant (p=0.014 vs. placebo) at the 600 mg

       dose.


-- Additional findings: signals suggestive of pharmacologic activity

   were observed for obesity, even in the in-patient setting.


    -- A greater proportion of subjects on drug experienced weight

       loss during the o
'"/>




Page: 1 2 3 4 

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird
Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II
Study of its Factor Xa Inhibitor at the XXI Congress of the
International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for
Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging
Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin
Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin
Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials &
Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III
Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results
and Additional Oral and Poster Presentations at the XXI Congress of
the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib
Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4
Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:1/14/2014)... Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw ... with accompanying instrumentation to place and insert the screw ... soft tissue (e.g. ligament) repair or reconstruction as it ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ... reduction (spacing) of the scaphoid and lunate while allowing ...
(Date:1/14/2014)... 2014   NuAire , a manufacturer of ergonomically designed ... with Hitachi Koki of Japan ... in North America . NuAire will utilize ... States and Canada to ... and accessories, training, pricing, as well as after sale service ...
(Date:1/14/2014)... VALHALLA, N.Y. , Jan. 14, 2014   ... the development of disease modifying therapeutics for Alzheimer,s ... the relocation of its corporate headquarters to ... 15, 2014 and expanded lease agreement for additional ... Oligomerix, which is focused on the development ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Inc. (NYSE Amex: NBS ) ("NeoStem" or ... on cell based therapeutics development, today reported on important ... trial for AMR-001, the lead product candidate of Amorcyte, ...  This comes after recent positive developments with respect to ...
... 2011 Ultragenyx Pharmaceutical Inc., a biotechnology company focused ... today announced the dosing of the first patient in ... body myopathy (HIBM). UX001 is an extended release formulation ... for HIBM, a severe, progressive, genetic neuromuscular disease caused ...
Cached Medicine Technology:NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter 2NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter 3NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter 4NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter 5Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease 2
(Date:3/14/2014)... the University of Adelaide has confirmed that a ... stages of the development of human brains. , Known as ... researchers for more than a decade, but in recent years ... development. , In a new paper published online in the ... international research team led by the University of Adelaide,s ...
(Date:3/13/2014)... fueled by the sun that is being developed ... around the world lacking safe and sustainable sanitation ... The self-contained, waterless toilet, designed and built using ... Gates Foundation, has the capability of heating human ... human waste and create biochar, a highly porous ...
(Date:3/13/2014)... a hard-hit ball or a lesser mortal navigating a ... watch on your surroundings when walking or running. Now, ... the body may get help in these fast-changing situations ... neurons to fire more strongly during locomotion. , There ... among different brain states during sleep, but the new ...
(Date:3/13/2014)... -- Cancer cells undergo extensive genetic alterations as they ... mutations, known as "drivers," help spur cells to grow ... for the ride. , MIT cancer biologists at the ... the Broad Institute have now performed the most comprehensive ... to develop cancer. The team discovered mutations and other ...
(Date:3/13/2014)... heart valves and blood vessels) is a primary ... death among both men and women in the ... and Prevention (CDC). , "Unfortunately, there currently ... can lead to acute cardiovascular events, such as ... failure," says Elena Aikawa, MD, PhD, Director of ...
Breaking Medicine News(10 mins):Health News:Critical role of one gene to our brain development 2Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 2Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 3Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 4Health News:These boosts are made for walkin' 2Health News:New view of tumors' evolution 2Health News:New view of tumors' evolution 3Health News:Novel marker and possible therapeutic target for cardiovascular calcification identified 2
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Sept. ... dysfunction are at increased risk for cardiovascular disease, stroke ... well accepted that cardiovascular disease is a risk factor ... erectile dysfunction is an independent risk factor for cardiovascular ...
... more than 100,000 area women, chronic vulvar pain (pain at ... intercourse, and sometimes sitting for long periods of time, painful, ... of Michigan, which surveyed 2,269 women in the metro Detroit ... experienced ongoing vulvar pain at some point in their lives. ...
... new study NYU School of Medicine researchers report that ... that have powerful effects against brain-destroying prion infections in ... prion diseases. The researchers, led by Thomas ... their findings in today,s online edition of PLoS ...
... may someday involve mining stem cells from the lining of ... new study published in the journal Molecular Therapy . ... the uterine lining into insulin-producing cells. The endometrium or ... cells generate uterine tissue each month as part of the ...
... CLEMSON, S.C. Researchers at the Clemson University ... psychology department have partnered with Perceptual Testing Inc. ... visual function, muscular coordination and driving. The ... board used in rehabilitation clinics across the country ...
... -- Pregnant women should get a flu shot to protect ... Pregnancy increases the risk of serious complications of flu, ... of Dimes. Not only does getting vaccinated offer protection ... protection to the baby once it,s born, said Dr. Alan ...
Cached Medicine News:Health News:Erectile Dysfunction May Be Linked With Cardiovascular Trouble 2Health News:Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan 2Health News:Screen finds an antidepressant and other drugs 2Health News:Yale researchers use uterine stem cells to treat diabetes 2Health News:Clemson researchers using interactive vision tool for driving studies 2Health News:Pregnant Women Reminded to Get Flu Vaccine 2
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm...
Complete with headrest, armrests, footrest and foot switch....
... patient's full weight. Footstep tilts out of the ... be raised and lowered by either a finger ... optional corded foot switch. Dual rotation locks on ... swivel the chair 330 without changing position. A ...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
Medicine Products: